Research into male hormonal contraception aims to suppress spermatogenesis through exogenous testosterone combined with progestins. By inhibiting gonadotropin release, sperm production decreases to levels insufficient for fertilization.
Clinical trials demonstrate promising efficacy, but challenges remain regarding reversibility, side effects, and long-term safety. Future development may expand contraceptive options and promote shared reproductive responsibility.
Andrology plays a pivotal role in evaluating erotic safety profiles and endocrine consequences of emerging contraceptive modalities.
Leave a Reply